According to GlobalData, combination therapy is the future of metabolic disease treatment, thus Pep2Tango’s candidate will ...

The use of GLP-1R agonists could be a great opportunity for patients whose diabetes is not completely under control with ...

A new study finds that weight loss drugs Like Ozempic could trigger bone loss. Doctors explain why, and how to protect ...

Natural supplements have “very mild effects” on weight loss based on what Dr. Ali has seen. There is some data to suggest ...

Pemvidutide's potential in obesity and MASH, combined with lean mass preservation, could make it a market leader in the ...

Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...

Bromocriptine is unique in that it does not have a specific receptor that mediates its action on glucose and lipid metabolism. Rather, its effects are mediated via resetting of dopaminergic and ...

By Dr. Sanchari Sinha Dutta, Ph.D. A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance ...

The GnRH agonists, which have greater potency and a longer half-life than native GnRH, produce an initial stimulation of pituitary gonadotrophs that results in secretion of follicle-stimulating ...

Statistically significant mean weight loss up to 5.5% over 28 days (4.9% placebo adjusted)Well-tolerated with no treatment-related dose ...